![CCO Neuroscience Podcast artwork](https://is2-ssl.mzstatic.com/image/thumb/Podcasts125/v4/43/26/0b/43260b9c-7ab4-877f-ae3e-390a58ffe3b5/mza_11250881568325215311.jpg/100x100bb.jpg)
Bipolar Disorder Research to Look For in 2023
CCO Neuroscience Podcast
English - December 07, 2022 21:30 - 24 minutes - 22.1 MB - ★★★★★ - 3 ratingsCourses Education Science Life Sciences movement disorders neuromuscular disorders mood disorders Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
In this episode, Greg W. Mattingly, MD, and Vladimir Maletic, MD, have a conversation about the ongoing bipolar disorder research and developments expected to have an impact in the coming year. They elaborate on the various neurotransmitters being investigated and how this research might change the future of patient care. From investigating new mechanisms of action to increased uptake of more novel therapeutics such as esketamine and neuromodulation, there is a lot to look forward to. As they note in the podcast: It’s an exciting time to be in the field of brain science!
Presenters:
Greg W. Mattingly, MD
Associate Clinical Professor
Psychiatry
Washington University School of Medicine
St Louis, Missouri
President
St Charles Psychiatry Associates
St Charles, Missouri
Vladimir Maletic MD
Clinical Professor
Department of Psychiatry
USC School of Medicine
Greenville, South Carolina
This content is based on a CE/CME program supported by independent educational grants from AbbVie and Intra-Cellular Therapies, Inc.
For more programs in this series, visit:
https://bit.ly/3ft1rYI